The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.
Also called NCT01828359
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 199 participants
- Registry
-
NCT01828359
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01828359. Randomized; quadruple masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
- Condition
- Hypertension
- Intervention (Drug)
- Amosartan® tab
- Intervention (Drug)
- Cozaar® plus pro tab
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct01828359- Content hash
9197aa64715b2452ae2a19872783d67c9f91c5266c44c334c555d1d777833000